| Trial ID: | L0861 |
| Source ID: | IRCT2015092924262N1
|
| Associated Drug: |
Turmeric
|
| Title: |
The effect of Turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes in patients with non-alcoholic fatty liver
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non alcoholic fatty liver disease. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention 1: Cap containing placebo, 2 gr flour for daily usage for 2 month. Intervention 2: Turmeric with daily dose 2 gr for 2 month.;Placebo;Treatment - Drugs;Cap containing placebo, 2 gr flour for daily usage for 2 month;Turmeric with daily dose 2
|
| Outcome Measures: |
Aspartate aminotransferase. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Concentration of AST with enzymatic method with kit.;Alanine aminotransferase. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Concentration of ALT in blood with enzymatic method with kit.;Gamma-glutamyl transpeptidase. Timepoint: Before intervention, 2 month later of intervention. Method of measurement: Concentration of GGT in blood with enzymatic method with kit.;Fasting blood sugar. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Concentration Fasting blood sugar with enzymatic method with kit.;Total cholestrol. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Concentration cholestrol of serum in fasting stage with enzymatic method with kit.;HDL-C. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Concentration of HDL-C serum in fasting stage with enzymatic method with kit.;LDL-C. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Concentration of LDL-C serum in fasting stage with fried method.;VLDL. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Concentration of VLDL serum in fasting stage with TG/5 Method.;Triglyciride. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Concentration of TG serum in fasting stage with enzymatic method with kit.;Hepatic steatosis. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Using ultrasound.;MDA. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Concentration of MDA serum in fasting stage with enzymatic method with kit.Weight. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Weight with Kilograms unit.;Body mass index. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Weight in Kilograms over Height in meters squared.;Total protein intake. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Dietary recall questionnaire.;Waist circumference. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Upper hip bone and place a measuring tape around the abdomen.;Hip circumference. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Hight waist circumference with measuring tape.;Blood pressure. Timepoint: Before intervention, 2 months after intervention. Method of measurement: (SBP-DBP)+ (DPB)/3.;AST/ALT Ratio. Timepoint: Before intervention, 2 months after intervention. Method of measurement: From divition of AST on ALT was made.;WHR. Timepoint: Before intervention, 2 months after intervention. Method of measurement: waist circumference to Hip circumference ratio.;Total energy intake. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Dietary recall questionnaire.;Total carbohydrate intake. Timepoint: Before intervention, 2 month later of intervention. Method of measurement: Dietary recall questionnaire.;Total fat intake. Timepoint: Before intervention, 2 months after intervention. Method of measurement: Dietary recall questionnaire.
|
| Sponsor/Collaborators: |
Nutrition and Metabolic Disorders Research Center, Ahvaz Jundishapur University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 years60 years
|
| Phases: |
Not applicable
|
| Enrollment: |
60
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
25/10/2015
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/20521
|
